Financings in Brief: Biomet
This article was originally published in The Gray Sheet
Executive Summary
Biomet: Board of directors authorizes repurchase of up to 4 mil. shares "in open market or privately negotiated transactions" between June 24, 1996 and June 23, 1997. Shares acquired will be used for general corporate purposes, "including use in the company's 401(k) and stock option plans," Biomet says. As of May 31, 1996, Biomet had approximately 115.8 mil. outstanding shares...
You may also be interested in...
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.